August 26, 2015
Daiichi Sankyo has received approval for an additional indication of tachycardiac atrial fibrillation for its hypertension, angina, and chronic heart failure treatment Artist Tablets 2.5 mg/10 mg/20 mg (carvedilol), it said on August 24. The company conducted PIII studies for...read more